Astera Labs, Inc. $ALAB Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC reduced its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 57.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,894 shares of the company’s stock after selling 12,205 shares during the period. Intech Investment Management LLC’s holdings in Astera Labs were worth $1,741,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Clearstead Advisors LLC boosted its stake in shares of Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the last quarter. Great Valley Advisor Group Inc. boosted its stake in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares during the last quarter. Rye Brook Capital LLC boosted its stake in Astera Labs by 1.1% during the 3rd quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after purchasing an additional 100 shares during the last quarter. Assetmark Inc. grew its holdings in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares in the last quarter. Finally, First Horizon Advisors Inc. raised its position in shares of Astera Labs by 12.4% in the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after buying an additional 108 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

NASDAQ ALAB opened at $120.00 on Friday. The firm’s 50-day moving average is $153.84 and its two-hundred day moving average is $170.53. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a market capitalization of $20.43 billion, a P/E ratio of 98.36, a PEG ratio of 2.24 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm’s revenue was up 91.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Loop Capital initiated coverage with a “Buy” and a $250 price target (roughly +100% upside vs. current levels), which can attract new buy-side interest and help lift sentiment. Benzinga
• Positive Sentiment: Recent quarterly results showed an EPS and revenue beat plus strong year-over-year revenue growth and positive guidance (Q1 EPS guide provided), supporting a fundamental growth story for the company and giving investors confidence in near-term execution. MarketBeat ALAB
• Positive Sentiment: Multiple sell-side firms have raised targets or maintain Buy/Outperform ratings (JPMorgan, Stifel, Northland, BNP Paribas Exane), and the consensus price target remains well above current trading levels—fuel for momentum traders and longer-term buyers. MarketBeat ALAB
• Neutral Sentiment: Media pieces are debating valuation and whether the stock is “too late” after strong 1‑year gains; these articles can drive retail interest but are mixed in directional impact. Yahoo Finance InsiderMonkey
• Neutral Sentiment: Reported short-interest figures in the feeds show contradictory/erroneous data (zeros and NaN values), so current short-interest signals are unreliable; treat these entries cautiously until corrected data is posted.
• Negative Sentiment: Insider selling: General Counsel Philip Mazzara sold 10,000 shares at about $117.47 (disclosed via SEC Form 4), reducing his ownership. Insider sales can be perceived negatively by some investors even if routine or for diversification/liquidity reasons. SEC Form 4

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. BNP Paribas Exane assumed coverage on shares of Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating on the stock. Barclays set a $165.00 price target on Astera Labs in a research report on Thursday, January 15th. Morgan Stanley reaffirmed an “overweight” rating and issued a $210.00 price target on shares of Astera Labs in a report on Wednesday, December 3rd. Raymond James Financial began coverage on Astera Labs in a research note on Friday, November 21st. They set a “hold” rating on the stock. Finally, Loop Capital assumed coverage on Astera Labs in a research note on Thursday. They issued a “buy” rating and a $250.00 target price for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $195.89.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the transaction, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jitendra Mohan sold 94,971 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the sale, the chief executive officer directly owned 1,452,739 shares in the company, valued at approximately $179,863,615.59. This trade represents a 6.14% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 216,792 shares of company stock valued at $26,777,569. Corporate insiders own 12.50% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.